Exo Therapeutics

Series-B+
exo-therapeutics.com Biotech & Healthcare Cambridge, United States Founded 2018 11-50
Total Funding $103M
Latest Round $78M Series-B+
Last Announced Oct 5, 2021
Investors 9 Backers
Decision Makers 5 Verified

About Exo Therapeutics

Building a new discovery paradigm to unlock intractable drug targets with exosites

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B+
Global Headquarters Cambridge, United States
Year Founded 2018
Team Size 11-50
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website exo-therapeutics.com
Domain Registered Date Dec 14, 2018

Social & Network Presence

X / Twitter Profile @ExoTherapeutics (202 followers) Created on Dec 2020
LinkedIn Corporate Not linked

Company Milestones & Timeline

5 Events
  1. Capital Raise

    Raised $78,000,000 · Series-B+

    fundraisingfox.com

  2. Capital Raise

    Raised $25,000,000 · Series-A

  3. Milestone

    X account created (@ExoTherapeutics)

    202 followers

  4. Milestone

    Website domain registered

    exo-therapeutics.com

  5. Milestone

    Company founded

    Cambridge, United States

Investors & Backers

9
6 Dimensions Capital
Biotechnology Value Fund
Casdin Capital
CRV
Morningside
Newpath Management
Nextech Invest
Novartis Venture Fund
Samsara Biocapital

Funding History

2 Rounds
Series-B+ · Oct 5, 2021
Series-A · Dec 16, 2020
$25,000,000 Source

Founders & Leadership

8

Antonio Gualberto

President of Research & Development ,Chief Medical Officer

Work email & phone locked Unlock →

Catherine Scholz

SVP, Head of Program Management

Work email & phone locked Unlock →

David R. Liu

Founder

Work email & phone locked Unlock →

Dorothy Lou Bailey

Senior Vice President, Corporate Development & Strategy

Work email & phone locked Unlock →

Michael Bruce

President & Chief Executive Officer

Work email & phone locked Unlock →

Nagesh K. Mahanthappa

Executive Chair

Work email & phone locked Unlock →

Paul Schneider

Senior Vice President, Finance & Operations

Work email & phone locked Unlock →

Stephanos Ioannidis

EVP, Drug Discovery

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts